Increasing security of supply for critical medical and pharmaceutical goods in the EU: Lessons from the COVID-19 pandemic

Jan Grumiller and Hannes Grohs

No 29, Briefing Papers from Austrian Foundation for Development Research (ÖFSE)

Abstract: This Briefing Paper examines the resilience of the medical product and pharmaceutical global value chains. Based on this assessment, policy recommendations are presented to increase supply security, including measures to improve the resilience of supply chains, and to expand stockpiling. We also highlight that industrial policy measures to promote reshoring should play a more important role, and that coordination on the EU-level is necessary. Given the large differences between products and supply chains within and between sectors, policies need to be tailored to specific products and product groups. Finally yet importantly, repercussions of EU policy on the Global South also need to be taken into account.

Keywords: supply chain resilience; reshoring; pharmaceuticals; medical products; COVID-19 (search for similar items in EconPapers)
Date: 2021
New Economics Papers: this item is included in nep-int
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.econstor.eu/bitstream/10419/231418/1/1750042029.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:zbw:oefseb:29

DOI: 10.60637/2021-bp29

Access Statistics for this paper

More papers in Briefing Papers from Austrian Foundation for Development Research (ÖFSE) Contact information at EDIRC.
Bibliographic data for series maintained by ZBW - Leibniz Information Centre for Economics ().